secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYPHERPUNK TECHNOLOGIES INC. (CYPH)
CIK:        0001509745
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001104659-23-072982
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Leap Therapeutics effecting 10-for-1 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse stock split ratio of 10-for-1, effective 5PM ET on June 20, 2023.
- Common stock to trade on split-adjusted basis under "LPTX" on Nasdaq starting June 21, 2023.
- Split approved by stockholders on June 16, 2023; board set final ratio.
- Purpose: increase per-share price to meet Nasdaq minimum bid requirement and facilitate Series X preferred conversion.
- No fractional shares issued; cash paid in lieu; all equity awards and warrants adjusted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1509745/000110465923072982/0001104659-23-072982-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1509745/000110465923072982/tm2319198d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-072982

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer